Novocure Ltd (NVCR) — 10-Q Filings
All 10-Q filings from Novocure Ltd. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
-
NovoCure Ltd. Files Q1 2026 10-Q Report
— Apr 30, 2026 Risk: low
NovoCure Ltd. filed its quarterly report on Form 10-Q for the period ending March 31, 2026. The filing includes financial statements and other disclosures relev -
NovoCure's Q3 Revenue Climbs, But Net Loss Widens to $37.3M
— Oct 30, 2025 Risk: high
NovoCure Ltd reported net revenues of $167.204 million for the three months ended September 30, 2025, an increase from $155.095 million in the same period of 20 -
NovoCure's Q2 Revenue Plunges 15.3%, Net Loss Widens
— Jul 24, 2025 Risk: high
NovoCure Ltd reported a significant decline in revenue for the second quarter of 2025, reaching $118.5 million, a 15.3% decrease from $139.9 million in the seco -
NovoCure Ltd. Files Q1 2025 10-Q Financial Report
— Apr 24, 2025 Risk: medium
NovoCure Ltd. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 202 -
NovoCure Ltd Files Q3 2024 10-Q Report
— Oct 30, 2024 Risk: medium
NovoCure Ltd filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the year. Key financial d -
NovoCure Ltd Files 2024 Q2 10-Q Financial Report
— Jul 25, 2024 Risk: medium
NovoCure Ltd filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024 and provides financial updates for the company. Ke -
NovoCure Files Q1 2024 Report, Meets Filing Requirements
— May 2, 2024 Risk: low
NovoCure Limited reported its quarterly results for the period ended March 31, 2024. The company is registered in Jersey and trades on the Nasdaq Stock Market u
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX